Free Testosterone vs Total Testosterone: What Patients Should Know
Your lab report says total testosterone is “normal.” You still have low libido, flat energy, weaker morning erections, or brain fog that will not lift. One of the most common—and least explained—reasons is that total testosterone is not the same as the testosterone your body can actually use. Understanding free testosterone, SHBG, and how labs are measured turns confusion into a clear evaluation plan.
For educational purposes only, not medical advice. Testosterone therapy is prescription treatment with risks (fertility suppression, elevated hematocrit, sleep apnea interaction, cardiovascular monitoring). Do not start or change therapy based on online content or a single lab value.
Related: What is free testosterone?, low testosterone symptoms, testosterone & ADHD overlap, why am I always tired?, insulin resistance, men's health & longevity.
The hook: normal total testosterone, persistent symptoms
James (composite patient) is 48. Total testosterone came back 420 ng/dL—squarely in the lab’s reference range. His primary care clinician said he was “fine.” Yet he stopped initiating intimacy, naps feel mandatory, and lifting weights no longer responds like it did five years ago. A men's health specialist repeats the test at 7 a.m., adds SHBG, and calculates free testosterone: SHBG is high; free T is low-normal. That pattern explains his symptoms better than the headline total number—and changes the conversation from marketing to medicine.
Your story may differ. Some men have low total testosterone with adequate free testosterone. Others have acceptable numbers on paper with no symptoms. The goal is not to find a reason to start testosterone replacement therapy (TRT). The goal is to interpret labs in context so you neither dismiss real hypogonadism nor treat a number without a diagnosis.
What total testosterone measures
Total testosterone is everything circulating in your blood: testosterone bound tightly to sex hormone-binding globulin (SHBG), testosterone bound loosely to albumin (and other proteins in smaller amounts), plus the tiny unbound fraction.
Guidelines from the Endocrine Society and the American Urological Association (AUA) use morning, fasting total testosterone as the first-line test because it is widely available and standardized when measured by accurate mass spectrometry methods. The AUA (reaffirmed 2024) cites a total testosterone below roughly 300 ng/dL as a reasonable cut-off to support diagnosis when symptoms are present—but only after confirmation on two separate early-morning samples.
Total testosterone is essential. It is also incomplete if SHBG is abnormal or if symptoms and numbers disagree.
What free testosterone measures
Free testosterone is the fraction not bound to proteins—about 2–3% of total in most men. It is the portion that can diffuse into cells and interact with androgen receptors. Clinicians also discuss bioavailable testosterone: free testosterone plus the albumin-bound fraction, which dissociates quickly and acts as a reserve.
Only free and bioavailable testosterone reflect what tissues can access in real time. SHBG-bound testosterone is largely inactive on a moment-to-moment basis—like cash locked in a vault while your wallet is empty.
Our short answer page defines this further: what is free testosterone?
Why both matter
Consider two men with total testosterone 450 ng/dL:
- Man A: SHBG 18 nmol/L → relatively more free testosterone → may feel well.
- Man B: SHBG 75 nmol/L → more testosterone locked up → may have low libido and fatigue despite “normal” total.
The Endocrine Society recommends obtaining free testosterone when total testosterone is near the lower limit of normal or when a condition alters SHBG—obesity, aging, thyroid disease, liver disease, HIV, certain medications. The AUA similarly notes that free or bioavailable testosterone is useful when binding proteins are altered, and suggests SHBG plus reliable free testosterone assessment when monitoring TRT if total levels look low-normal but symptoms persist.
Symptoms that should prompt careful pairing of history and labs—not a reflex TRT sale—include reduced libido, loss of morning erections, infertility difficulty, depressed mood overlapping with androgen deficiency, decreased muscle mass, and unexplained anemia in men (per guideline frameworks). Many of these overlap with non-hormonal fatigue causes; that is why pattern matters.
The role of SHBG
SHBG is produced mainly in the liver. It binds testosterone with high affinity. When SHBG rises, free testosterone falls at the same total. When SHBG falls, free testosterone rises.
SHBG tends to increase with: aging, hyperthyroidism, liver disease, some medications, low insulin states in some contexts.
SHBG tends to decrease with: obesity, insulin resistance, metabolic syndrome, androgen use, growth hormone excess, some inflammatory states.
A Veterans Affairs cohort analysis (PMID 25777143) found obesity’s association with lower SHBG was stronger than aging’s association with higher SHBG. Obese men had lower total testosterone than non-obese men, but calculated free testosterone was often similar—meaning total testosterone alone can suggest deficiency when free testosterone is not actually low.
Longitudinal data in obese men further show that many with low total and low SHBG maintain normal free testosterone and do not develop hypogonadal symptoms; a smaller subgroup with low total and low free testosterone is more likely to have sexual symptoms—supporting use of free testosterone to avoid overtreatment.
Why symptoms and labs do not always match
Beyond SHBG, common reasons for mismatch include:
- Wrong timing: Testosterone is diurnal; afternoon samples can look falsely normal or low.
- Single test: Both Endocrine Society and AUA emphasize repeat morning fasting measurements.
- Assay variability: Different labs and methods shift results; comparing years-old values to a new platform is unreliable.
- Inaccurate “free T” on the report: Direct analog immunoassays often disagree with equilibrium dialysis—sometimes by large margins. Ask how free testosterone was determined.
- Non-androgen causes of symptoms: Obstructive sleep apnea, depression, thyroid disease, iron deficiency, and ADHD can mimic low testosterone. Low testosterone symptoms are nonspecific.
- Secondary hypogonadism: Low LH/FSH with low testosterone may indicate pituitary problems; prolactin should be considered when clinically indicated—not skipped because a TRT clinic wants a quick start.
Sleep, obesity, stress, and testosterone
Obesity and insulin resistance
Excess adiposity suppresses the hypothalamic-pituitary-gonadal axis and lowers SHBG. Weight loss often raises total testosterone and SHBG. For men with metabolic risk, addressing insulin resistance and weight may improve symptoms and labs more than jumping to TRT.
Sleep apnea
Obstructive sleep apnea is linked to lower total testosterone and sexual dysfunction. Meta-analyses of CPAP therapy, however, show no consistent significant increase in total or free testosterone after treatment—so CPAP should be pursued for sleep and cardiovascular health, not as a testosterone booster. The Endocrine Society lists untreated severe obstructive sleep apnea among conditions where testosterone therapy should not be started without addressing apnea first.
Sleep deprivation and stress
Short sleep and chronic stress affect mood, libido, and energy through cortisol and autonomic pathways—not only through testosterone. Fixing sleep may help symptoms even when testosterone is borderline.
Aging
Total testosterone declines roughly 1% per year in many men after midlife, but aging also tends to raise SHBG. Guidelines caution against treating every older man with a low-normal number; individualized risk–benefit discussion is required.
Current evidence patients should know
- Diagnosis requires symptoms + low testosterone, confirmed on repeat testing—not a screening number alone (Endocrine Society; AUA).
- Free testosterone measurement when total is borderline or SHBG is altered; prefer equilibrium dialysis or validated calculations—not unvalidated direct assays (Endocrine Society position; AUA testing white paper).
- TRAVERSE trial (NEJM 2023): In more than 5,000 men with hypogonadism symptoms, cardiovascular risk, and testosterone below 300 ng/dL on two occasions, testosterone gel was noninferior to placebo for major adverse cardiac events over ~22 months of treatment. However, testosterone-treated men had higher rates of atrial fibrillation, pulmonary embolism, and acute kidney injury. This reinforces careful patient selection and monitoring—not fear marketing, but not casual prescribing either.
- Fertility: Exogenous testosterone suppresses sperm production. Men planning conception need explicit counseling; alternatives such as clomiphene or hCG may be considered in select secondary hypogonadism cases under specialists.
Deeper treatment framing: when is testosterone therapy appropriate? and clinical answer.
Common myths
- Myth: “Normal total testosterone rules out a hormone problem.” Reality: Check SHBG and free testosterone when symptoms fit.
- Myth: “Low total always means I need TRT.” Reality: Obesity often lowers total while free remains adequate.
- Myth: “The free testosterone on my lab slip is always accurate.” Reality: Method matters; direct immunoassays are often misleading.
- Myth: “Higher total is always better.” Reality: Supraphysiologic levels on therapy carry monitoring burdens; symptoms should drive treatment.
- Myth: “TRT is anti-aging for any man over 40.” Reality: Guidelines advise against routine TRT by age alone.
- Myth: “CPAP will fix my testosterone.” Reality: Meta-analyses show inconsistent testosterone rises; treat apnea for its own sake.
- Myth: “Fatigue equals low T.” Reality: See fatigue differential workup first when appropriate.
- Myth: “Online clinics with symptom quizzes are enough.” Reality: Diagnosis requires proper assays, repeats, and exclusion of reversible causes.
Practical next steps
- Retest correctly: Morning (ideally before 10 a.m.), fasting if possible, when acutely ill tests are deferred.
- Confirm twice before labeling lifelong hypogonadism.
- Ask for SHBG when total is borderline or obesity/thyroid/medications apply.
- Ask how free testosterone was measured—calculation from validated inputs vs equilibrium dialysis vs direct assay.
- Screen mimics: Sleep apnea symptoms, depression screen, thyroid if indicated, ferritin if fatigue-heavy periods, ADHD history if concentration dominates.
- Discuss fertility before any testosterone prescription.
- Lifestyle first when relevant: Weight loss, sleep apnea treatment, strength training, alcohol moderation—can improve testosterone and symptoms without TRT.
When evaluation is appropriate
Seek clinician-led evaluation for sustained low libido, marked loss of morning erections, infertility, significant muscle loss with weakness, or fatigue that persists after addressing sleep and mood—especially if morning total testosterone is low or borderline on repeat testing.
Urgent issues (chest pain, stroke symptoms, priapism, suicidal ideation) require emergency care—not hormone optimization.
A Meet & Greet at Siya Health is an informational telehealth visit to review whether your pattern fits men's hormone evaluation, metabolic co-care, or referral—not an automatic TRT enrollment.
FAQ
- What is free testosterone?
- The biologically active unbound fraction. Full answer.
- Which number matters more?
- Both. Total is the screening anchor; free (and SHBG context) explains many symptom mismatches.
- Can I have normal total and low free?
- Yes—often with high SHBG.
- Can I have low total and normal free?
- Yes—often with low SHBG in obesity.
- Should I order my own lab panel?
- Results need clinical interpretation; avoid starting therapy from direct-to-consumer numbers alone.
- Does ADHD affect this?
- ADHD and low testosterone can mimic each other. Overlap guide.
- Will TRT fix my mood?
- Some men with documented deficiency improve; others need depression or sleep treatment. TRT is not a universal mood drug.
- What about women?
- This article focuses on men; women have lower circulating testosterone with different reference ranges and clinical contexts.
Internal linking path
Hormone hub path: Free testosterone defined → this article → symptoms → therapy appropriateness → men's health services.
Metabolic/sleep path: Insulin resistance → fatigue guide → return here if morning erections and libido remain affected.
Continue reading
Selected references
Bhasin S et al., Endocrine Society testosterone therapy guideline, J Clin Endocrinol Metab 2018; AUA testosterone deficiency guideline (reaffirmed 2024); Rosner W et al., measuring testosterone position statement; Kapoor D et al., obesity and SHBG, Clin Endocrinol 2015 (PMID 25777143); Lincoff AM et al., TRAVERSE trial, N Engl J Med 2023; CPAP and testosterone meta-analyses (Front Endocrinol 2019; PLOS One); Vermeulen A free testosterone calculation literature.